EZH2 and neoplasm: In addition, in vivo, the subcutaneous tumor formation rate in mice implanted with EZH2 knockout clones was obviously reduced (from 100 to 0%) compared to that in mice implanted with wild-type SKOV3 cells (p = 0.0021; Figure 2E).